Reply to Ensor et al
暂无分享,去创建一个
[1] C. Ensor,et al. The risk of ventricular-assist device infections differs by device type. , 2010, Clinical Infectious Diseases.
[2] J. Thornby,et al. Risk factors and outcomes of fungal ventricular-assist device infections. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] A. Shorr,et al. Fungal infections in the ICU. , 2009, Infectious disease clinics of North America.
[4] M. Flattery,et al. Cellular immunity impaired among patients on left ventricular assist device for 6 months. , 2008, The Annals of thoracic surgery.
[5] M. Oz,et al. Quantitative changes in T-cell populations after left ventricular assist device implantation: relationship to T-cell apoptosis and soluble CD95. , 1999, Circulation.
[6] Silviu Itescu,et al. Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist de vice , 1999, The Lancet.